AssetMark Inc’s Verona Pharma VRNA Stock Holding History

AssetMark Inc’s Portfolio VRNA Stock Details VRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-93	Closed	-$9.92K	–	3476
2025 Q3	$9.92K	Hold	93	–	–	﹤0.01%	2116
2025 Q2	$8.8K	Hold	93	–	–	﹤0.01%	1990
2025 Q1	$5.91K	Hold	93	–	–	﹤0.01%	1954
2024 Q4	$4.32K	Buy	+93	New	+$3.49K	﹤0.01%	1963

Other funds holding VRNA

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

AssetMark Inc's VRNA Position: Q4 2025 in Review

AssetMark Inc sold out of Verona Pharma (VRNA) in Q4 2025, closing a stake of 93 shares — an estimated $9.92K sold.

AssetMark Inc first reported a position in VRNA in Q4 2024 and held it in 4 quarters. The position peaked at $9.92K in Q3 2025. 1 fund tracked by Wall St. Rank holds VRNA as of Q4 2025.

AssetMark Inc reported no remaining Verona Pharma position as of Q4 2025 after selling out during the quarter.
AssetMark Inc sold 93 Verona Pharma shares in Q4 2025, an estimated $9.92K.
AssetMark Inc first reported a position in Verona Pharma in Q4 2024 and held it in 4 quarters.
AssetMark Inc's Verona Pharma position peaked at $9.92K in Q3 2025.
1 fund tracked by Wall St. Rank held Verona Pharma as of Q4 2025.

Based on AssetMark Inc's 13F filing for Q4 2025, filed 23 Jan 2026.